Obesity

DisabilitiesDrugs (Pharmaceuticals)Federal-State Relations (US)Health Insurance and Managed CareMedicaidObesityPrices (Fares, Fees and Rates)Regulation and Deregulation of IndustryRepublican PartyStates (US)Trump, Donald JTrumpRX (Web Site)United States Politics and Government

Trump Promotes Program to Reduce Medicaid Drug Prices

Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.

Read More
BusinessHealthInequalityNHSObesityPharmaceuticals industryPrivate healthcareScienceSocietyUK newsWeight-loss drugs

‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs

Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis findsThe high cost of weight-loss medication is a “regressive tax on being thin” because the outlay outweighs any …

Read More